Targeted therapies in epithelial ovarian cancer.

J Oncol · 2010 · PMC2810474 · PMID 20111741

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Conversely, there may be significant improvements in time-to-event endpoints such as time-to-progression or PFS, and yet objective responses may be rare.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.